AbCellera Biologics Inc

Trend Analysis of AbCellera Biologics Inc

Momentum has clearly turned favorable again, with recent solid performance that stands in sharp contrast to the underperformance of previous years. The stock is showing renewed investor interest, likely linked to a re-rating of its growth profile and platform quality, but the trajectory still needs to be monitored as the long-term history remains choppy. For a retail investor, the signal is positive in the short